These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 17477865
21. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Mockenhaupt FP, Ehrhardt S, Dzisi SY, Teun Bousema J, Wassilew N, Schreiber J, Anemana SD, Cramer JP, Otchwemah RN, Sauerwein RW, Eggelte TA, Bienzle U. Trop Med Int Health; 2005 Jun; 10(6):512-20. PubMed ID: 15941413 [Abstract] [Full Text] [Related]
22. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Koram KA, Abuaku B, Duah N, Quashie N. Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584 [Abstract] [Full Text] [Related]
24. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Checchi F, Roddy P, Kamara S, Williams A, Morineau G, Wurie AR, Hora B, Lamotte Nd, Baerwaldt T, Heinzelmann A, Danks A, Pinoges L, Oloo A, Durand R, Ranford-Cartwright L, Smet M, Sierra Leone Antimalarial Efficacy Study Collaboration. Trop Med Int Health; 2005 Feb; 10(2):146-53. PubMed ID: 15679557 [Abstract] [Full Text] [Related]
26. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G. Bull World Health Organ; 2002 Feb; 80(7):538-45. PubMed ID: 12163917 [Abstract] [Full Text] [Related]
27. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania. Mbugi EV, Mutayoba BM, Malisa AL, Balthazary ST, Nyambo TB, Mshinda H. Malar J; 2006 Oct 31; 5():94. PubMed ID: 17076899 [Abstract] [Full Text] [Related]
30. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia. Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B. Acta Trop; 2013 Dec 31; 128(3):636-41. PubMed ID: 24055717 [Abstract] [Full Text] [Related]
36. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR. Trop Med Int Health; 2008 Nov 31; 13(11):1384-91. PubMed ID: 19055622 [Abstract] [Full Text] [Related]
37. Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda. Checchi F, Piola P, Kosack C, Ardizzoni E, Klarkowski D, Kwezi E, Priotto G, Balkan S, Bakyaita N, Brockman A, Guthmann JP. Trop Med Int Health; 2004 Apr 31; 9(4):445-50. PubMed ID: 15078262 [Abstract] [Full Text] [Related]
39. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014. Mishra S, Bharti PK, Shukla MM, Ali NA, Kashyotia SS, Kumar A, Dhariwal AC, Singh N. Pathog Glob Health; 2017 Jun 31; 111(4):186-194. PubMed ID: 28549390 [Abstract] [Full Text] [Related]
40. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo. Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F. Trop Med Int Health; 2007 Oct 31; 12(10):1164-71. PubMed ID: 17956498 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]